These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2209768)

  • 21. Effect of six weekly transfusions on canine marrow grafts: tests for sensitization and abrogation of sensitization by procarbazine and antithymocyte serum.
    Weiden PL; Storb R; Slichter S; Warren RP; Sale GE
    J Immunol; 1976 Jul; 117(1):143-50. PubMed ID: 6593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple minor histocompatibility antigen-specific cytotoxic T lymphocyte clones can be generated during graft rejection after HLA-identical bone marrow transplantation.
    Marijt WA; Kernan NA; Diaz-Barrientos T; Veenhof WF; O'Reilly RJ; Willemze R; Falkenburg JH
    Bone Marrow Transplant; 1995 Jul; 16(1):125-32. PubMed ID: 7581111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of graft-versus-host disease by immunosuppressive agents after transplantation of DLA-nonidentical canine marrow.
    Storb R; Kolb HJ; Deeg HJ; Weiden PL; Appelbaum F; Graham TC; Thomas ED
    Bone Marrow Transplant; 1986 Dec; 1(2):167-77. PubMed ID: 3332131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of major histocompatibility complex and non-major histocompatibility complex encoded antigens in generation of bile duct lesions during hepatic graft-vs.-host responses mediated by helper or cytotoxic T cells.
    Williams FH; Thiele DL
    Hepatology; 1994 Apr; 19(4):980-8. PubMed ID: 8138273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of transfusions from unrelated DLA-matched or mismatched donors upon marrow grafts between DLA-identical canine littermates.
    Storb R; Raff RF; Appelbaum FR; Schuening FW; Sandmaier BM; Graham TC
    Transplantation; 1988 Aug; 46(2):334-6. PubMed ID: 3043788
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of recombinant canine stem cell factor, a c-kit ligand, on hematopoietic recovery after DLA-identical littermate marrow transplants in dogs.
    Schuening FG; von Kalle C; Kiem HP; Appelbaum FR; Deeg HJ; Pepe M; Gooley T; Graham TC; Hackman RC; Storb R
    Exp Hematol; 1997 Nov; 25(12):1240-5. PubMed ID: 9357967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T cell-depleted, nonmyeloablative bone marrow transplantation.
    Cho SG; Shuto Y; Soda Y; Nakazaki Y; Izawa K; Uchimaru K; Takahashi S; Tani K; Tojo A; Asano S
    Exp Hematol; 2004 Dec; 32(12):1246-54. PubMed ID: 15588949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
    Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Engraftment of DLA-nonidentical unrelated canine marrow after high-dose fractionated total body irradiation.
    Deeg HJ; Storb R; Shulman HM; Weiden PL; Graham TC; Thomas ED
    Transplantation; 1982 Apr; 33(4):443-6. PubMed ID: 7041371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Failure of antithymocyte serum postgrafting to overcome "resistance" to DLA-nonidentical canine marrow grafts.
    Storb R; Raff RF; Appelbaum FR; Schuening F; Sandmaier B; Shulman H; Deeg HJ; Graham T
    Transplantation; 1988 Jan; 45(1):236-9. PubMed ID: 3276053
    [No Abstract]   [Full Text] [Related]  

  • 33. Bone marrow engraftment following unrelated donor transplantation utilizing busulfan and cyclophosphamide preparatory chemotherapy.
    Klein JL; Avalos BR; Belt P; Taylor CA; Ezzone SA; Scholl MD; Fisher J; Young D; Copelan EA
    Bone Marrow Transplant; 1996 Apr; 17(4):479-83. PubMed ID: 8722342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leucyl-leucine methyl ester treatment of donor cells permits establishment of immunocompetent parent----F1 chimeras that are selectively tolerant of host alloantigens.
    Thiele DL; Calomeni JA; Lipsky PE
    J Immunol; 1987 Oct; 139(7):2137-42. PubMed ID: 3309052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Failure of anti-MHC antibodies to prevent GVHD in DLA mismatched unrelated canine marrow recipients.
    Ladiges WC; Storb R; Raff RF; Appelbaum FR; Sandmaier B; Schuening F; Graham T
    Bone Marrow Transplant; 1990 Jan; 5(1):43-6. PubMed ID: 2297589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies of the use of L-leucyl-L-leucine methyl ester in canine allogeneic marrow transplantation.
    Raff RF; Severns EM; Storb R; Graham TC; Sale G; Schuening FG; Appelbaum FR
    Transplantation; 1993 Jun; 55(6):1244-9. PubMed ID: 8516809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. G-CSF-mobilized peripheral blood mononuclear cells added to marrow facilitates engraftment in nonmyeloablated canine recipients: CD3 cells are required.
    Zaucha JM; Zellmer E; Georges G; Little MT; Storb R; Storer B; Torok-Storb B
    Biol Blood Marrow Transplant; 2001; 7(11):613-9. PubMed ID: 11760149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of host cells involved in resistance to marrow grafts in dogs transplanted from unrelated DLA-nonidentical donors.
    Raff RF; Deeg HJ; Loughran TP; Graham TC; Aprile JA; Sale GE; Storb R
    Blood; 1986 Oct; 68(4):861-8. PubMed ID: 3530349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intensified postgrafting immunosuppression failed to assure long-term engraftment of dog leukocyte antigen-identical canine marrow grafts after 1 gray total body irradiation.
    Sorror ML; Leisenring W; Mielcarek M; Baron F; Diaconescu R; Hogan WJ; Graves SS; Storb R
    Transplantation; 2008 Apr; 85(7):1023-9. PubMed ID: 18408584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pretreatment of murine donor grafts with L-leucyl-L-leucine methyl ester: elimination of graft-versus-host disease without detrimental effects on engraftment.
    Blazar BR; Thiele DL; Vallera DA
    Blood; 1990 Feb; 75(3):798-805. PubMed ID: 1967541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.